Ogunbiyi O A, Scholefield J H, Sharp F, Ginsberg R, Rogers K
Department of Surgery, Clinical Sciences Centre, Northern General Hospital, Sheffield.
J Clin Pathol. 1992 Oct;45(10):889-93. doi: 10.1136/jcp.45.10.889.
To evaluate the usefulness of counting nucleolar organiser region associated proteins (AgNORs) in the management of anal squamous neoplasia.
Using a silver staining technique for NOR associated proteins, 32 routinely processed paraffin wax embedded sections of anal epithelium were assessed. These consisted of normal anal epithelium (n = 9), anal intraepithelial neoplasia (AIN) grades I (n = 5), and III (n = 13), and invasive squamous neoplasia of the anus (n = 5).
The median AgNOR counts for every 100 cells are as follows: normal anal epithelium 2.15 (95% CI 1.89-3.94); AIN I 3.21 (95% CI 2.89-7.14); AIN III 4.32 (95% CI 4.00-8.10); and invasive squamous cell carcinoma of the anus 5.51 (95% CI 2.48-10.62). There were significant differences between AgNOR counts in anal cancer and normal epithelium (p < 0.05; Mann-Whitney U test)), AIN III and normal anal epithelium (p < 0.005), and AIN III and AIN I (p < 0.05). No significant differences were observed between AIN I and normal anal epithelium, anal cancer and AIN I, and anal cancer and AIN III. There was a considerable degree of overlap among the different groups.
Despite the strong association between AgNOR values and degree of dysplasia, the variability within pathological grade may preclude the adoption of this technique on its own as a prognostic indicator. It may, however, be useful in conjunction with other markers of neoplastic growth such as c-myc oncogene amplification or overexpression as a marker of disease progression in AIN and invasive anal squamous cell cancer.
评估计数核仁组成区相关蛋白(AgNORs)在肛管鳞状上皮肿瘤管理中的作用。
采用NOR相关蛋白的银染技术,对32例常规处理的肛管上皮石蜡包埋切片进行评估。这些切片包括正常肛管上皮(n = 9)、肛管上皮内瘤变(AIN)I级(n = 5)、III级(n = 13)以及肛管浸润性鳞状上皮肿瘤(n = 5)。
每100个细胞的AgNOR计数中位数如下:正常肛管上皮为2.15(95%可信区间1.89 - 3.94);AIN I级为3.21(95%可信区间2.89 - 7.14);AIN III级为4.32(95%可信区间4.00 - 8.10);肛管浸润性鳞状细胞癌为5.51(95%可信区间2.48 - 10.62)。肛管癌与正常上皮的AgNOR计数之间存在显著差异(p < 0.05;Mann - Whitney U检验),AIN III级与正常肛管上皮之间存在显著差异(p < 0.005),AIN III级与AIN I级之间存在显著差异(p < 0.05)。AIN I级与正常肛管上皮之间、肛管癌与AIN I级之间以及肛管癌与AIN III级之间未观察到显著差异。不同组之间存在相当程度的重叠。
尽管AgNOR值与发育异常程度之间存在密切关联,但病理分级内的变异性可能使该技术无法单独作为预后指标。然而,它可能与其他肿瘤生长标志物(如c - myc癌基因扩增或过表达)联合使用,作为AIN和肛管浸润性鳞状细胞癌疾病进展的标志物。